Paper36909339
The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness.
Andrade de Oliveira K and 3 others. Front Endocrinol (Lausanne), 2023. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness. Papers, record 36909339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36909339
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Tumor Microenvironment |
Source PubMed
References186
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31564558 | Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. | Mol Cell | 2019 | https://conductscience.org/library/papers/31564558 | PubMed |
| 2 | 26122181 | ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer. | Nat Rev Clin Oncol | 2015 | https://conductscience.org/library/papers/26122181 | PubMed |
| 3 | 22722201 | The landscape of cancer genes and mutational processes in breast cancer. | Nature | 2012 | https://conductscience.org/library/papers/22722201 | PubMed |
| 4 | 12847142 | Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12847142 | PubMed |
| 5 | 26340526 | Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. | Cell Stem Cell | 2015 | https://conductscience.org/library/papers/26340526 | PubMed |
| 6 | 26797784 | Extracellular vesicles in breast cancer drug resistance and their clinical application. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26797784 | PubMed |
| 7 | 35687565 | Recent advances in isobaric labeling and applications in quantitative proteomics. | Proteomics | 2022 | https://conductscience.org/library/papers/35687565 | PubMed |
| 8 | 33082214 | Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33082214 | PubMed |
| 9 | 11348316 | Marked Intratumoral Heterogeneity of the Proto-Oncogene Her-2/neu Determined by Three Different Detection Systems. | Breast J | 1999 | https://conductscience.org/library/papers/11348316 | PubMed |
| 10 | 17344846 | Patterns of somatic mutation in human cancer genomes. | Nature | 2007 | https://conductscience.org/library/papers/17344846 | PubMed |
| 11 | 25117005 | Focal adhesion signaling and therapy resistance in cancer. | Semin Cancer Biol | 2015 | https://conductscience.org/library/papers/25117005 | PubMed |
| 12 | 31428575 | Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer. | Front Oncol | 2019 | https://conductscience.org/library/papers/31428575 | PubMed |
| 13 | 6323188 | Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor. | Eur J Cancer Clin Oncol | 1984 | https://conductscience.org/library/papers/6323188 | PubMed |
| 14 | 16369246 | Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer. | MedGenMed | 2005 | https://conductscience.org/library/papers/16369246 | PubMed |
| 15 | 24919951 | Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells. | Breast Cancer Res | 2014 | https://conductscience.org/library/papers/24919951 | PubMed |
| 16 | 32268136 | Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. | Exp Cell Res | 2020 | https://conductscience.org/library/papers/32268136 | PubMed |
| 17 | 32312891 | Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32312891 | PubMed |
| 18 | 30205045 | The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. | Cancer Cell | 2018 | https://conductscience.org/library/papers/30205045 | PubMed |
| 19 | 31563959 | The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial. | JAMA Oncol | 2020 | https://conductscience.org/library/papers/31563959 | PubMed |
| 20 | 31091374 | Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31091374 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794706 | Population-Associated Molecular Variation in Histologically Normal Breast Tissue Is Associated with Distinct Baseline Transcriptional States. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794706 | PubMed |
| 42552061 | Focused ultrasound thermal ablation and CD40 agonism reprograms breast tumor immunity to drive regression and memory. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42552061 | PubMed |
| 42351956 | Toward More Translational Tumor Models: Breast dECM-Based 3D Systems Capture Native Microenvironmental Cues. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42351956 | PubMed |
| 42301532 | Programmed cell death and metastatic evolution in breast cancer: the role of anoikis, necroptosis, and ferroptosis. | Apoptosis | 2026 | https://conductscience.org/library/papers/42301532 | PubMed |
| 42271577 | Metabolic Fingerprinting of Urine Reveals Metabolite Changes in Women With Breast Cancer. | Cancer Med | 2026 | https://conductscience.org/library/papers/42271577 | PubMed |
| 42063127 | The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications. | BMC Med | 2026 | https://conductscience.org/library/papers/42063127 | PubMed |
| 41997307 | Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells. | Biochim Biophys Acta Mol Basis Dis | 2026 | https://conductscience.org/library/papers/41997307 | PubMed |
| 41835391 | Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory. | bioRxiv | 2026 | https://conductscience.org/library/papers/41835391 | PubMed |
| 41465262 | Multi-Level Profiling of MAPK-Associated Genes and MicroRNAs Uncovers Regulatory Networks in Breast Cancer Subtypes. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465262 | PubMed |
| 40960690 | Artificial intelligence-assisted PET imaging for predicting neoadjuvant chemotherapy response in breast cancer: a systematic review and meta-analysis. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/40960690 | PubMed |
| 40874301 | Molecular crossroads: identifying MAPK proteins bridging SMAD and dopamine pathways in breast cancer. | Cell Cycle | 2025 | https://conductscience.org/library/papers/40874301 | PubMed |
| 40679587 | Therapeutic evaluation of paclitaxel co-loaded PLGA nanoparticles with imatinib, protamine-imatinib, and gefitinib: comparative in vitro studies in MDA-MB-231 breast cancer cells and in vivo investigations in rats. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/40679587 | PubMed |
| 40510030 | FGFR1 overexpression promotes resistance to PI3K inhibitor alpelisib in luminal breast cancer cells through receptor tyrosine kinase signaling-mediated activation of the estrogen receptor. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/40510030 | PubMed |
| 40224980 | The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40224980 | PubMed |
| 40183319 | BUB1, miR-495-3p, and E2F1/E2F8 axis is associated with poor prognosis of breast cancer patients and infiltration of Th2 cells in the tumor microenvironment. | Cancer Biomark | 2025 | https://conductscience.org/library/papers/40183319 | PubMed |
| 39998578 | From silent partners to potential therapeutic targets: macrophages in colorectal cancer. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/39998578 | PubMed |
| 39763599 | Case report: Bone marrow metastasis and bone marrow necrosis occurring 11 years after ductal carcinoma in situ of the breast. | Front Oncol | 2024 | https://conductscience.org/library/papers/39763599 | PubMed |
| 39696346 | Exosomes and breast cancer angiogenesis; Highlights in intercellular communication. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39696346 | PubMed |
| 39269086 | Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities-A State-of-the-Art Review. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/39269086 | PubMed |
| 39131188 | In silico evaluation of potential breast cancer receptor antagonists from GC-MS and HPLC identified compounds in Pleurotus ostreatus extracts. | RSC Adv | 2024 | https://conductscience.org/library/papers/39131188 | PubMed |
Genes86
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36909339
GET https://conductscience.org/api/papers/v1/36909339/references?page=2